About Axcend
Axcend is a company based in Provo (United States) founded in 2018 was acquired by Catalyze in July 2024. It operates as a Direct-to-Consumer (D2C). Axcend has raised $3.55 million across 8 funding rounds from investors including HHS, National Institute of General Medical Sciences and Catalyze Partners. The company has 8 employees. Axcend offers products and services including Axcend Focus LC, Auto Focus, In Focus, and Focus Array.
- Headquarter Provo, United States
- Employees 8
- SectorsChemicals & Materials
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website axcendcorp.com
- Social LinkedIn X Facebook
- Acquired by Catalyze (Jul 2024)
- Legal Name Axcend
Products & Services of Axcend
Axcend offers a comprehensive portfolio of products and services, including Axcend Focus LC, Auto Focus, In Focus, and Focus Array.
Compact HPLC system for flexible, repeatable results anywhere.
Automated sample injection for consistent, low carry-over results.
Real-time reaction monitoring for precise process analytical technology.
Smallest DAD for enhanced capillary HPLC detection sensitivity.
Funding Insights of Axcend
Axcend has successfully raised a total of $3.55M across 8 strategic funding rounds. The most recent funding activity was a Grant round of $1.12 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.5M
- Total Rounds 8
- Last Round Grant β $1.1M
- First Round $1.0M
(Jun 2018)
- Investors Count 2
All 8 funding rounds of Axcend with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2022 | $1.1M | Grant | β | β | |
| Mar 2021 | – | Grant | β | β | |
| Mar 2021 | $750,000 | Debt – Conventional | β | β | β |
| May 2020 | $1.7M | Grant | β | β | |
| Mar 2020 | $1.7M | Debt – Conventional | β | β | β |
| May 2019 | $2.5M | Seed | β | β | β |
| Sep 2018 | $135,024 | Grant | β | β | |
| Jun 2018 | $1.0M | Seed | β | β | β |
3 investors in total: 3 institutional.
Investors in Axcend
Axcend has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include HHS, National Institute of General Medical Sciences and Catalyze Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
Basic research is supported to advance medical sciences. | – | nigms.nih.gov | Bethesda, United States | |
Commercialization of high-tech innovations and monetization of assets is facilitated by Catalyze Partners. | – | catalyze.partners | - |
Investor details for Axcend
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Axcend
4 dated milestones of Axcend across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Axcend is founded.
- Funding First funding round of $1.0M.
- Funding Latest funding round, Grant, of $1.1M.
- Exit Acquired by Catalyze.
Web traffic of Axcend
The website of Axcend (axcendcorp.com) receives about 2.8K visits a month.
- Monthly visits2.8K
▲ 22.5% vs previous month
Similar companies to Axcend
10 companies that operate in the same segment as Axcend (Petrochemicals & Derivatives), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Aramco is recognized as a leading producer of energy and chemicals globally. | 1993 | Dhahran, Eastern Province, Saudi Arabia | – | – | – | |
Petrochemicals, chemicals, and thermoplastic resins are produced for businesses. | 2002 | Sao Paulo, Brazil | – | USD 12.91 B | 8,380 | |
Produces and supplies specialty chemicals for energy, petrochemicals, and industrial applications worldwide. | 1992 | Mumbai, Maharashtra, India | – | USD 479.49 M | 976 | |
Lubricants, additives, vehicle care, and repair liquids are manufactured. | 1957 | Ulm, Baden-wurttemberg, Germany | – | – | – | |
PET resins, PET products, and wool yarn are manufactured. | 1994 | Bangkok, Thailand | – | USD 14.12 B | 175 | |
Polybutene-based petrochemicals are produced by the company. | 1990 | Chennai, Tamil Nadu, India | – | USD 62.67 M | 194 | |
Petrochemicals and derivatives are manufactured in Thailand. | 2011 | Rayong, Thailand | – | USD 15.39 B | – | |
Petrochemical products are manufactured and supplied by SCGC. | 1994 | Bangkok, Thailand | – | USD 35.91 M | – | |
Petrochemical products and materials are supplied globally for key industries. | 1957 | Tokyo, Tokyo, Japan | – | USD 750.07 K | – | |
Refined fuels, polymers, and monomers are produced for industrial applications. | 2005 | Rabigh, Makkah Region, Saudi Arabia | – | – | 2,944 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Axcend
Axcend was founded in 2018.
Axcend is headquartered in Provo, United States. It is registered at Provo, Utah, United States.
Axcend is a funded company, having raised a total of $3.55M across 8 funding rounds to date. The company's 1st funding round was a Seed of $1M, raised on Jun 2018.
Axcend has 8 employees.
Axcend is known for creating compact, low-flow HPLC systems that deliver reliable chromatography results in various settings. These systems are designed for industries such as pharmaceutical, chemical, and educational sectors. Solutions offered by Axcend include real-time monitoring, automated sample injection, and high-sensitivity detection, reducing solvent use, energy consumption, and waste. Their technology is adapted for tight lab spaces or remote locations, supporting sustainability and operational efficiency.
Axcend offers Axcend Focus LC, Auto Focus, In Focus, and Focus Array.
Axcend has 3 investors. Key investors include HHS, National Institute of General Medical Sciences, and Catalyze Partners.
Axcend operates through Axcend.
Yes. Axcend was acquired by Catalyze in July 2024.
